Ruxolitinib for the Treatment of T-Cell Large Granular Lymphocytic Leukemia
Learn more about:
Related Clinical Trial
A Study of Ruxolitinib and Duvelisib in People With Lymphoma
Ruxolitinib for the Treatment of T-Cell Large Granular Lymphocytic Leukemia
ABC008 in Subjects With T-cell Large Granular Lymphocytic Leukemia (T-LGLL)
Siltuximab in Large Granular Lymphocytic Leukemia (LGLL)
Safety, PK, PD, Clinical Activity of KT-333 in Adult Patients With Refractory Lymphoma, Large Granular Lymphocytic Leukemia, Solid Tumors
Oral Azacitidine for the Treatment of Relapsed or Refractory T-cell Large Granular Lymphocytic Leukemia
Tipifarnib in Treating Patients With Anemia or Neutropenia and Large Granular Lymphocyte Leukemia
Effect of Cyclosporine Therapy on Gene Expression in Patients With Large Granular Lymphocyte Leukemia
Methotrexate Followed by Fludarabine in Patients With T-Cell Large Granular Lymphocytic Leukemia
Hu-Mik-beta1 to Treat T-Cell Large Granular Lymphocytic Leukemia